Economic resources consumption structure in severe hypoglycemia episodes: a systematic review and meta-analysis

References

• World Health Organization. Diabetes, Fact sheet N°312. Available from: www.who.int/mediacentre/factsheets/fs312/en/ [Last accessed 8 April 2015]
   Google Scholar
• Shuyu Ng C, Toh MP, Ko Y, et al. Direct Medical Cost of Type 2 Diabetes in Singapore. PLoS One 2015;10:e0122795
   Google Scholar
• Borges NB, Ferraz MB, Chacra AR. The cost of type 2 diabetes in Brazil: evaluation of a diabetes care center in the city of São Paulo, Brazil. Diabetol Metab Syndr 2014;6:122
   PubMed Web of Science ®Google Scholar
• Zhuo X, Zhang P, Barker L, et al. The lifetime cost of diabetes and its implications for diabetes prevention. Diabetes Care 2014;37:2557-64
   PubMed Web of Science ®Google Scholar
• Marcellusi A, Viti R, Mecozzi A, Mennini FS. The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach. Eur J Health Econ 2014. [Epub ahead of print]
   Google Scholar
• Ng CS, Lee JY, Toh MP, et al. Cost-of-illness studies of diabetes mellitus: a systematic review. Diabetes Res Clin Pract 2014;105:151-63
   PubMed Web of Science ®Google Scholar
• Czech M, Kawalec P. Literature Concerning Diabetes Costs in Central and Eastern Europe – a Systematic Review and Comparison to Western Europe, USA and Canada. Interdisc J Econ & Bus L 2012;1:28-50
   Google Scholar
• Domeikienė A, Vaivadaitė J, Ivanauskienė R, et al. Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania. Medicina (Kaunas) 2014;50:54-60
   PubMed Web of Science ®Google Scholar
• Ganz ML, Wintfeld NS, Li Q, et al. Severe hypoglycemia rates and associated costs among type 2 diabetics starting basal insulin therapy in the United States. Curr Med Res Opin 2014;30:1991-2000
   PubMed Web of Science ®Google Scholar
• Foos V, Varol N, Curtis BH, et al. Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States. J Med Econ 2015;11:1-13
   Google Scholar
• Ward A, Alvarez P, Vo L, et al. Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD. 2012;J Med Econ 2014;17:176-83
   Google Scholar
• Parekh WA, Ashley D, Chubb B, et al. Approach to assessing the economic impact of insulin-related hypoglycaemia using the novel Local Impact Of Hypoglycaemia Tool. Diabet Med 2015; Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Jönsson L, Bolinder B, Lundkvist J. Cost of hypoglycemia in patients with Type 2 diabetes in Sweden. Value Health 2006;9:193-8
   PubMed Web of Science ®Google Scholar
• Jakubczyk M, Pawęska J, Niewada M, et al. Risk of severe hypoglycaemia for various treatment regimens – a systematic review and meta-analysis of observational studies. JHPOR 2014;2:76-93
   Google Scholar
• Nitzoufras I. Bayesian Modeling Using WinBUGS. John Wiley & Sons, Inc., Hoboken, New Jersey; 2009
   Google Scholar
• The Diabetes Control and Complications Trial Research Group. Resource utilization and costs of care in the diabetes control and complications trial. Diabetes Care 1995;18:1468-78
   PubMed Web of Science ®Google Scholar
• Elliott J, Jacques RM, Kruger J, et al. Research: Educational and Psychological Issues Substantial reductions in the number of diabetic ketoacidosis and severe hypoglycaemia episodes requiring emergency treatment led to reduced costs after structured education in adults with Type 1 diabetes. Diabet Med 2014;31:847-53
   PubMed Web of Science ®Google Scholar
• Hammer M, Lammert M, Mejías SM, et al. Costs of managing severe hypoglycaemia in three European countries. J Med Econ 2009;12:281-90
   PubMedGoogle Scholar
• Hendrieckx C, Halliday JA, Bowden JP, et al. Severe hypoglycaemia and its association with psychological well-being in Australian adults with type 1 diabetes attending specialist tertiary clinics. Diabetes Res Clin Pract 2014;103:430-6
   PubMed Web of Science ®Google Scholar
• Honkasalo M, Elonheimo O, Sane T. Many diabetic patients with recurrent severe hypoglycemias hold a valid driving license. A community-based study in insulin-treated patients with diabetes. Traffic Inj Prev 2010;11:258-62
   PubMed Web of Science ®Google Scholar
• Leese GP, Wang J, Broomhall J, et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 2003;26:1176-80
   PubMed Web of Science ®Google Scholar
• Norgaard K, Scaramuzza A, Bratina N, et al. Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study. Diabetes Technol Ther 2013;15:273-80
   PubMed Web of Science ®Google Scholar
• O’Brien JA, Shomphe LA, Kavanagh PL, et al. Direct medical costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care 1998;21:1122-8
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial. JAMA 1996;276:1409-15
   PubMed Web of Science ®Google Scholar
• Abraira C, Colwell JA, Nuttall FQ, et al. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care 1995;18:1113-23
   PubMed Web of Science ®Google Scholar
• O’Brien JA, Patrick AR, Caro J. Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000. Clin Ther 2003;25:1017-38
   PubMed Web of Science ®Google Scholar
• Orozco-Beltrán D, Mezquita-Raya P, Ramírez de Arellano A, et al. Self-reported frequency and impact of hypoglycaemic events in Spain. Diabetes Ther 2014;5:155-68
   PubMed Web of Science ®Google Scholar
• Parsaik AK, Carter RE, Pattan V, et al. Population-based study of severe hypoglycaemia requiring emergency medical service assistance reveals unique findings. J Diabetes Sci Technol 2012;6:65-73
   PubMedGoogle Scholar
• Reviriego J, Gomis R, Marañés JP, et al. Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia. Int J Clin Pract 2008;62:1026-32
   PubMed Web of Science ®Google Scholar
• Rowe BH, Singh M, Villa-Roel C, et al. Acute management and outcomes of patients with diabetes mellitus presenting to Canadian emergency departments with hypoglycemia. Can J Diabetes 2015;39:55-64
   PubMed Web of Science ®Google Scholar
• Vexiau P, Mavros P, Krishnarajah G, et al. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes Obes Metab 2008;10:16-24
   PubMed Web of Science ®Google Scholar
• Willis WD, Diago-Cabezudo JI, Madec-Hily A, et al. Medical resource use, disturbance of daily life and burden of hypoglycaemia in insulin-treated patients with diabetes: results from a European online survey. Expert Rev Pharmacoecon Outcomes Res 2013;13:123-30
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0, The Cochrane Collaboration. Available from: http://handbook.cochrane.org/ [Last accessed 1 April 2015]
   Google Scholar
• Donnelly LA, Morris AD, Frier BM, et al. Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med 2005;22:749-55
   PubMed Web of Science ®Google Scholar
• ORIGIN Trial Investigators. Mellbin LG, Rydén L, Riddle MC, et al. Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial. Eur Heart J 2013;34(40):3137-44
   PubMed Web of Science ®Google Scholar